Richard Bernstein Advisors LLC purchased a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 66,062 shares of the company's stock, valued at approximately $5,165,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of GEHC. LGT Financial Advisors LLC lifted its stake in GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock valued at $25,000 after buying an additional 251 shares in the last quarter. Capital Performance Advisors LLP acquired a new stake in GE HealthCare Technologies in the 3rd quarter valued at about $26,000. Ashton Thomas Securities LLC acquired a new stake in GE HealthCare Technologies in the 3rd quarter valued at about $26,000. Darwin Wealth Management LLC acquired a new stake in GE HealthCare Technologies in the 3rd quarter valued at about $31,000. Finally, Continuum Advisory LLC raised its holdings in GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after acquiring an additional 168 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.
GE HealthCare Technologies Trading Down 2.3 %
Shares of NASDAQ:GEHC traded down $2.05 during mid-day trading on Friday, reaching $87.35. 4,214,406 shares of the company were exchanged, compared to its average volume of 2,887,457. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The firm has a market cap of $39.94 billion, a price-to-earnings ratio of 20.17, a P/E/G ratio of 3.19 and a beta of 1.15. The firm's 50-day simple moving average is $86.17 and its 200 day simple moving average is $86.10. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to analysts' expectations of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. Equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.
Wall Street Analyst Weigh In
GEHC has been the subject of a number of recent research reports. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and increased their price objective for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company raised their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a report on Friday, February 14th. Finally, Citigroup raised their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a report on Thursday, February 13th. One analyst has rated the stock with a sell rating, three have issued a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $97.67.
Check Out Our Latest Stock Analysis on GEHC
GE HealthCare Technologies Profile
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
See Also
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
